1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BLACK DIAMOND THERAPEUTICS INC
Black Diamond Therapeutics Inc XNAS: BDTX

Black Diamond Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic t...

Read More
2.78 -0.15 (-5.12%)
58.81% Fall from 52W High
1.3M
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Black Diamond Therapeutics Inc is on 06 Aug 2025 for the purpose of Black Diamond Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
39.5 / 100
Momentum Score
Technically Neutral
57.2 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
No estimates available

13

S

15

W

0

O

2

T

SWOT Analysis

Black Diamond Therapeutics... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..